Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA.

Masuda K, Teshima-Kondo S, Mukaijo M, Yamagishi N, Nishikawa Y, Nishida K, Kawai T, Rokutan K.

PLoS Med. 2008 May 20;5(5):e94. doi: 10.1371/journal.pmed.0050094.

2.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
3.

Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.

Kuo LJ, Hung CS, Chen WY, Chang YJ, Wei PL.

J Surg Res. 2013 Nov;185(1):264-72. doi: 10.1016/j.jss.2013.05.020. Epub 2013 May 29.

PMID:
23759331
4.

A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.

Guan H, Zhou Z, Wang H, Jia SF, Liu W, Kleinerman ES.

Clin Cancer Res. 2005 Apr 1;11(7):2662-9.

5.

Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements.

Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, Goodall GJ.

Mol Biol Cell. 1999 Apr;10(4):907-19.

6.

Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.

Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS.

Cancer Res. 2005 Jul 1;65(13):5881-9.

7.

Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.

Khaliq S, Jahan S, Pervaiz A, Ali Ashfaq U, Hassan S.

Virol J. 2011 May 13;8:221. doi: 10.1186/1743-422X-8-221.

8.

[Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].

Chen XL, Liu LC, Xu ZG, Li Z, Li RW, Gao RJ, Wang S, Zhang M, Guo H.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):578-82. Chinese.

PMID:
19102933
9.

Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.

Shen HL, Xu W, Wu ZY, Zhou LL, Qin RJ, Tang HR.

Leuk Res. 2007 Apr;31(4):515-21. Epub 2006 Oct 10.

PMID:
17034851
10.

Effect of interferon alpha and cell cycle progression on translation mediated by the hepatitis C virus 5' untranslated region: a study using a transgenic mouse model.

Takeda Y, Okoshi S, Suzuki K, Yano M, Gangemi JD, Jay G, Asakura H, Aoyagi Y.

J Viral Hepat. 2004 Jan;11(1):33-44.

PMID:
14738556
11.

Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.

Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.

Oncol Rep. 2007 Oct;18(4):801-9.

PMID:
17786339
12.

A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.

Zhao X, Li DC, Zhao H, Li Z, Wang JX, Zhu DM, Zhou J, Cen JN.

Oncol Rep. 2012 Mar;27(3):628-36. doi: 10.3892/or.2011.1602. Epub 2011 Dec 21.

PMID:
22200682
13.

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

Zhou J, Gan N, Zhang W, Lu W, Xie X.

J Obstet Gynaecol Res. 2010 Apr;36(2):232-8. doi: 10.1111/j.1447-0756.2010.01196.x.

PMID:
20492371
14.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.

Cancer Res. 2003 Jun 15;63(12):3403-12.

15.

Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.

Wang J, Shi YQ, Yi J, Ye S, Wang LM, Xu YP, He M, Kong XM.

J Dig Dis. 2008 Nov;9(4):228-37. doi: 10.1111/j.1751-2980.2008.00352.x.

PMID:
18959596
16.

Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.

Tao J, Tu YT, Huang CZ, Feng AP, Wu Q, Lian YJ, Zhang LX, Zhang XP, Shen GX.

Br J Dermatol. 2005 Oct;153(4):715-24.

PMID:
16181451
17.

Induced apoptosis in human prostate cancer cells by blocking of vascular endothelial growth factor by siRNA.

Deezagi A, Ansari-Majd S, Vaseli-Hagh N.

Clin Transl Oncol. 2012 Oct;14(10):791-9. doi: 10.1007/s12094-012-0868-1. Epub 2012 Jul 24.

PMID:
22855159
19.

Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.

Wang TS, Ding QQ, Guo RH, Shen H, Sun J, Lu KH, You SH, Ge HM, Shu YQ, Liu P.

Biomed Pharmacother. 2010 May;64(5):333-8. doi: 10.1016/j.biopha.2009.06.002. Epub 2009 Oct 21.

PMID:
19914791
20.

Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.

Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pagès G.

Mol Biol Cell. 2007 Nov;18(11):4648-58. Epub 2007 Sep 12.

Supplemental Content

Support Center